AR094879A1 - Formulación oral y suspensión de un fármaco oncológico - Google Patents
Formulación oral y suspensión de un fármaco oncológicoInfo
- Publication number
- AR094879A1 AR094879A1 ARP140100584A ARP140100584A AR094879A1 AR 094879 A1 AR094879 A1 AR 094879A1 AR P140100584 A ARP140100584 A AR P140100584A AR P140100584 A ARP140100584 A AR P140100584A AR 094879 A1 AR094879 A1 AR 094879A1
- Authority
- AR
- Argentina
- Prior art keywords
- suspension
- oral formulation
- oncological drug
- oncological
- drug
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
- B65D81/00—Containers, packaging elements, or packages, for contents presenting particular transport or storage problems, or adapted to be used for non-packaging purposes after removal of contents
- B65D81/32—Containers, packaging elements, or packages, for contents presenting particular transport or storage problems, or adapted to be used for non-packaging purposes after removal of contents for packaging two or more different materials which must be maintained separate prior to use in admixture
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Inorganic Chemistry (AREA)
- Dispersion Chemistry (AREA)
- Mechanical Engineering (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
Abstract
Formulación oral y suspensión de una composición farmacéutica que comprende sonidegib que es útil para tratar enfermedades relacionadas con la actividad de la vía de señalización del Erizo que incluyen, por ejemplo, cánceres del cerebro, músculo, piel y próstata; meduloblastoma; adenocarcinomas pancreáticos; y carcinomas de pulmón de células pequeñas.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201361768803P | 2013-02-25 | 2013-02-25 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR094879A1 true AR094879A1 (es) | 2015-09-02 |
Family
ID=50288200
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP140100584A AR094879A1 (es) | 2013-02-25 | 2014-02-25 | Formulación oral y suspensión de un fármaco oncológico |
Country Status (11)
Country | Link |
---|---|
US (2) | US9943520B2 (es) |
EP (1) | EP2958550B1 (es) |
JP (1) | JP6310484B2 (es) |
AR (1) | AR094879A1 (es) |
AU (1) | AU2014220339B2 (es) |
ES (1) | ES2935528T3 (es) |
IL (2) | IL240629B (es) |
PL (1) | PL2958550T3 (es) |
TW (2) | TWI684462B (es) |
WO (1) | WO2014128661A1 (es) |
ZA (1) | ZA201506012B (es) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105906616B (zh) * | 2015-03-30 | 2018-09-04 | 苏州晶云药物科技有限公司 | Lde225单磷酸盐的晶型及其制备方法 |
WO2017163258A1 (en) * | 2016-03-22 | 2017-09-28 | Msn Laboratories Private Limited | Process for the preparation of n-[6-(cis-2,6-dimethylmorpholin-4-yl)pyridine-3-yl]-2- methyl-4'-(trifiuoromethoxy) [1,1' -biphenyi]-3-carboxamide and its polymorphs thereof |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ZA831186B (en) * | 1982-03-22 | 1983-11-30 | Upjohn Ltd | Gelled pge2/triacetin solutions |
CN102159570B (zh) | 2008-09-17 | 2014-01-15 | 诺瓦提斯公司 | N-[6-(顺式-2,6-二甲基吗啉-4-基)吡啶-3-基]-2-甲基-4’-(三氟甲氧基)[1,1’-联苯]-3-甲酰胺的盐 |
AR077490A1 (es) * | 2009-07-21 | 2011-08-31 | Novartis Ag | Composiciones farmaceuticas topicas para el tratamiento de una condicion hiperproliferativa de la piel |
JP5722781B2 (ja) * | 2009-08-26 | 2015-05-27 | 武田薬品工業株式会社 | 縮合複素環誘導体およびその用途 |
JP2012094104A (ja) * | 2010-09-29 | 2012-05-17 | Omron Corp | 情報処理装置および方法、並びにプログラム |
-
2014
- 2014-02-21 ES ES14710642T patent/ES2935528T3/es active Active
- 2014-02-21 WO PCT/IB2014/059161 patent/WO2014128661A1/en active Application Filing
- 2014-02-21 EP EP14710642.1A patent/EP2958550B1/en active Active
- 2014-02-21 US US14/769,110 patent/US9943520B2/en active Active
- 2014-02-21 AU AU2014220339A patent/AU2014220339B2/en active Active
- 2014-02-21 PL PL14710642.1T patent/PL2958550T3/pl unknown
- 2014-02-21 JP JP2015558590A patent/JP6310484B2/ja active Active
- 2014-02-24 TW TW103106127A patent/TWI684462B/zh active
- 2014-02-24 TW TW109101263A patent/TWI696470B/zh active
- 2014-02-25 AR ARP140100584A patent/AR094879A1/es not_active Application Discontinuation
-
2015
- 2015-08-17 IL IL240629A patent/IL240629B/en active IP Right Grant
- 2015-08-19 ZA ZA2015/06012A patent/ZA201506012B/en unknown
-
2017
- 2017-11-20 US US15/817,854 patent/US10426781B2/en active Active
-
2020
- 2020-08-20 IL IL276838A patent/IL276838B/en active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
US10426781B2 (en) | 2019-10-01 |
US20180071305A1 (en) | 2018-03-15 |
IL240629A0 (en) | 2015-10-29 |
TW202019392A (zh) | 2020-06-01 |
ZA201506012B (en) | 2020-01-29 |
AU2014220339B2 (en) | 2016-12-01 |
EP2958550A1 (en) | 2015-12-30 |
ES2935528T3 (es) | 2023-03-07 |
EP2958550B1 (en) | 2022-08-17 |
IL240629B (en) | 2020-09-30 |
IL276838A (en) | 2020-10-29 |
US20160008369A1 (en) | 2016-01-14 |
TWI696470B (zh) | 2020-06-21 |
TWI684462B (zh) | 2020-02-11 |
WO2014128661A1 (en) | 2014-08-28 |
JP2016510724A (ja) | 2016-04-11 |
US9943520B2 (en) | 2018-04-17 |
IL276838B (en) | 2021-05-31 |
JP6310484B2 (ja) | 2018-04-11 |
PL2958550T3 (pl) | 2023-01-16 |
AU2014220339A1 (en) | 2015-09-17 |
TW201442738A (zh) | 2014-11-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NI201600071A (es) | Compuestos de inhibidor de autotaxina | |
PH12016501139A1 (en) | Bicyclic heterocycle compounds and their uses in therapy | |
CO2017001493A2 (es) | Kits que comprenden inhibidores tigit y agentes anticáncer | |
BR112015019995A2 (pt) | Combinação terapêutica envolvendo anticorpos contra claudina 18.2 para tratamento de câncer | |
PH12016500582A1 (en) | Heterocyclic compounds and uses thereof | |
CR20140108A (es) | Compuesto de ciclopropanoamina | |
CL2015003801A1 (es) | Formulaciones de anticuerpos y metodos | |
DOP2015000185A (es) | Pirimidinas fusionadas sustituidas con trifluorometilo y sus usos | |
AR090774A1 (es) | Dihidrato de un compuesto de benzotiofeno o de una de sus sales y proceso para su produccion | |
MX2019006878A (es) | Uso de flecainida como un agente anti-conexina y metodo para potenciar los efectos de un farmaco psicotropico. | |
NI201600070A (es) | Inhibidores tetracíclicos de autotaxina | |
EA201691032A1 (ru) | Производные изохромена в качестве ингибиторов фосфоинозитид-3-киназ | |
MX2016000794A (es) | Composiciones farmaceuticas de pancreatina de potencia alta. | |
PH12016500978A1 (en) | Piperazine derivatives having multimodal activity against pain | |
MX2016000480A (es) | Composiciones farmaceuticas de pancreatina de alta potencia. | |
EA201792571A1 (ru) | Терапевтическое применение l-4-хлорокинуренина | |
MX2016006603A (es) | Compuestos piperidinicos con actividad multimodal contra el dolor. | |
EA201591450A1 (ru) | Фармацевтический состав, содержащий гликозаминогликан | |
MX2016006087A (es) | Formulaciones de desintegracion rapida y metodos de uso. | |
AR094879A1 (es) | Formulación oral y suspensión de un fármaco oncológico | |
MX2020006075A (es) | Composiciones farmaceuticas de bendamustina. | |
IN2013MU03118A (es) | ||
DOP2015000290A (es) | Benzoxazoles sustituidos | |
PH12020500472A1 (en) | Autotaxin inhibitor compounds | |
TR201716203A1 (tr) | Yeni umeklidinyum formülasyonları. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC | Refusal |